Cargando…
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
The success of the first licensed mRNA-based vaccines against COVID-19 has created a widespread interest on mRNA technology for vaccinology. As expected, the number of mRNA vaccines in preclinical and clinical development increased exponentially since 2020, including numerous improvements in mRNA fo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166207/ https://www.ncbi.nlm.nih.gov/pubmed/37168860 http://dx.doi.org/10.3389/fimmu.2023.1172691 |